179024-72-7 Usage
Uses
Used in Pharmaceutical Industry:
4-CHLORO-6-METHOXY-QUINOLINE-3-CARBOXYLIC ACID is used as a key intermediate in the synthesis of various drugs, particularly anti-malarial and anti-bacterial agents. Its antimicrobial, antifungal, and antiparasitic properties make it a valuable ingredient in the development of new medications.
Used in Antimicrobial Applications:
4-CHLORO-6-METHOXY-QUINOLINE-3-CARBOXYLIC ACID is used as an antimicrobial agent for its ability to inhibit the growth of various microorganisms, including bacteria and fungi. Its unique chemical structure allows it to target specific cellular processes, making it a promising candidate for the development of new antimicrobial drugs.
Used in Antiparasitic Applications:
4-CHLORO-6-METHOXY-QUINOLINE-3-CARBOXYLIC ACID is used as an antiparasitic agent for its ability to combat parasitic infections. Its antiparasitic properties make it a potential candidate for the development of new treatments for parasitic diseases.
Used in Anti-inflammatory Applications:
4-CHLORO-6-METHOXY-QUINOLINE-3-CARBOXYLIC ACID has been studied for its potential anti-inflammatory effects. It may be used as an anti-inflammatory agent to reduce inflammation and alleviate symptoms associated with various inflammatory conditions.
Used in Anti-cancer Applications:
4-CHLORO-6-METHOXY-QUINOLINE-3-CARBOXYLIC ACID has been studied for its potential anti-cancer effects. It may be used as an anti-cancer agent to inhibit the growth and proliferation of cancer cells, making it a promising candidate for the development of new cancer treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 179024-72-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,9,0,2 and 4 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 179024-72:
(8*1)+(7*7)+(6*9)+(5*0)+(4*2)+(3*4)+(2*7)+(1*2)=147
147 % 10 = 7
So 179024-72-7 is a valid CAS Registry Number.
179024-72-7Relevant academic research and scientific papers
SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS
-
Paragraph 0197, (2019/05/22)
The disclosure provides compounds of Formula I, which may be useful as aldehyde dehydrogenase inhibitors and the pharmaceutically acceptable salts thereof. The variables, J, R4, G, Q, and ring A are defined herein. Aldehyde dehydrogenase inhibitors of Formula I are useful for treating a variety of conditions including cancer and inflammation. The disclosure includes methods for using compounds and salts of Formula I to treat colon cancer, pancreatic cancer, nasopharyngeal carcinoma, thyroid cancer, prostate cancer, ovarian cancer, head and neck squamous cell carcinoma, lung cancer, hepatocellular carcinoma, leukemia, brain tumorsbreast cancer, atherosclerosis, ischaemic heart disease, acne vulgaris, asthma, autoimmune diseases, autoinflammatory diseases, chronic prostatitis, glomerulonephritis, inflammatory bowel disease, pelvic inflammatory disease, reperfusion injury, rheumatoid arthritis, sarcoidosis, transplant rejection, vasculitis, and interstitial cystitis. The disclosure also includes pharmaceutical compositions containing a compound or salt of Formula I.
